UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC. (Exact name of registrant as specified in its charter) DELAWARE 04-3744954 (State or ...

Globus Medical, Inc. (NYSE:GMED) Q2 2020 Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants Brian Kearns - Senior Vice President of Investor Relations Dave Demski - President and Chief Executive Officer Dan Scavilla - Executive Vice President and Chief Commercial Officer Keith Pfeil - Senior Vice President and Chief Financial Officer Conference Call Participants Matt Miksic - Credit Suisse Shagun Singh - Wells Fargo Securities Richard Newitter - SVB Leerink Kaila Krum - Truist Securitie ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC. (Exact name of registrant as specified in its charter) DELAWARE 04-3744954 (State or othe ...

Globus Medical, Inc. (NYSE:GMED) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Brian Kearns - Senior VP of Investor Relations Dave Demski - President and CEO Dan Scavilla - Executive Vice President, Chief Commercial Officer Keith Pfeil - Senior Vice President and Chief Financial Officer Conference Call Participants Matt Miksic - Credit Suisse Mason Austen - Morgan Stanley Richard Newitter - SVB Leerink Matt O'Brien - Piper Sandler Kaila Krum - SunTrust Mike Matson - Needham an ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC. (Exact name of registrant as specified in its charter) DELAWARE 04-3744954 (State or oth ...

Globus Medical, Inc. (NYSE:GMED) Q4 2019 Results Earnings Conference Call February 20, 2020 4:30 PM ET Company Participants Brian Kearns - Senior Vice President, Business Development and Investor Relations David Demski - President and Chief Executive Officer Keith Pfeil - Senior Vice President and Chief Financial Officer Daniel Scavilla - Executive Vice President and Chief Commercial Officer Conference Call Participants Matthew Miksic - Credit Suisse Matthew O'Brien - Piper Sandler Kaila Krum - SunTrust Rob ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC. (Exact name of registrant as specified in its charter) DELAWARE 04-3744954 (State or other ju ...

Globus Medical, Inc. (NYSE:GMED) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Brian Kearns – Senior Vice President-Business Development and Investor Relations Dave Demski – President and Chief Executive Officer Dan Scavilla – Executive Vice President and Chief Commercial Officer Keith Pfeil – Senior Vice President and Chief Financial Officer Conference Call Participants Matt Miksic – Credit Suisse Shagun Singh – Wells Fargo Richard Newitter – SVB Leerink Craig Bijou – Ca ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC. (Exact name of registrant as specified in its charter) DELAWARE 04-3744954 Indicate ...

Globus Medical, Inc. (NYSE:GMED) Q2 2019 Results Conference Call August 1, 2019 4:30 PM ET Company Participants Brian Kearns - SVP of Business Development and Investor Relations. Dave Demski - President and Chief Executive Officer Dan Scavilla - EVP, Chief Commercial Officer and Chief Financial Officer Conference Call Participants Matt Miksic - Credit Suisse Larry Biegelsen - Wells Fargo Craig Bijou - Cantor Fitzgerald Richard Newitter - SVB Leerink David Lewis - Morgan Stanley Ryan Zimmerman - BTIG Mike ...